Literature DB >> 24135299

Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis.

Rebecca E H Whiting1, Kristina Narfström, Gang Yao, Jacqueline W Pearce, Joan R Coates, Leilani J Castaner, Martin L Katz.   

Abstract

Late-infantile neuronal ceroid lipofuscinosis (CLN2) is a hereditary neurological disorder characterized by progressive retinal degeneration and vision loss, cognitive and motor decline, seizures, and pronounced brain atrophy. The progressive loss of neurological functions eventually leads to death, usually by the early teenage years. Utilizing a canine model of CLN2, therapeutic studies to inhibit the brain and retinal degenerations are currently under way. Using this dog model, studies were undertaken to compare quantitative assessments of the pupillary light reflex (PLR) and electroretinography (ERG) as tools for evaluating the effects of the disease on retinal function. The PLR and ERG were recorded in normal and CLN2-affected Dachshunds at 2 month intervals between the ages of 4 and 10 months. Using custom instrumentation for quantitative PLR assessments, a series of white light stimuli of varying intensity was used to elicit pupil constriction, and pupil images were recorded using continuous infrared illumination and an infrared-sensitive camera. Electroretinography was used to evaluate retinal function in the same dogs. As the disease progressed, affected dogs exhibited progressive and profound declines in ERG amplitudes under both scotopic and photopic conditions. With low intensity light stimuli, CLN2 was also accompanied by progressive deficits in the PLR. Changes in the PLR to dim light stimuli included significant deficits in latency, constriction velocity, constriction amplitude, and redilation velocity. However, despite the almost complete loss of detectable ERG responses by disease end stage, the PLR to bright stimuli was well preserved throughout the disease progression. These findings demonstrate that the PLR is much more sensitive than the ERG in detecting residual retinal function in animal models of retinal degenerative disease. The preservation of the PLR in dogs with profoundly depressed ERGs correlates with a preservation of visually-mediated behavior even late in the disease progression. Quantitative analysis of the PLR has potential as a biomarker in animal models of retinal degenerative diseases and in evaluating the efficacy of therapeutic interventions in preserving retinal function.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  electroretinogram; lysosomal storage disease; neurodegeneration; neuronal ceroid lipofuscinosis; pupillary light reflex; retinal degeneration

Mesh:

Year:  2013        PMID: 24135299      PMCID: PMC3845481          DOI: 10.1016/j.exer.2013.10.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  34 in total

1.  Automated standardized pupillometry with optical method for purposes of clinical practice and research.

Authors:  F Fotiou; K N Fountoulakis; A Goulas; L Alexopoulos; A Palikaras
Journal:  Clin Physiol       Date:  2000-09

2.  Guidelines for clinical electroretinography in the dog.

Authors:  Kristina Narfström; Björn Ekesten; Serge G Rosolen; Bernhard M Spiess; Christine L Percicot; Ron Ofri
Journal:  Doc Ophthalmol       Date:  2002-09       Impact factor: 2.379

3.  Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice.

Authors:  R J Lucas; S Hattar; M Takao; D M Berson; R G Foster; K-W Yau
Journal:  Science       Date:  2003-01-10       Impact factor: 47.728

4.  Gene therapy restores vision in a canine model of childhood blindness.

Authors:  G M Acland; G D Aguirre; J Ray; Q Zhang; T S Aleman; A V Cideciyan; S E Pearce-Kelling; V Anand; Y Zeng; A M Maguire; S G Jacobson; W W Hauswirth; J Bennett
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

5.  Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis.

Authors:  Brian R Vuillemenot; Martin L Katz; Joan R Coates; Derek Kennedy; Pascale Tiger; Shinichi Kanazono; Peter Lobel; Istvan Sohar; Su Xu; Rhea Cahayag; Steve Keve; Eugen Koren; Stuart Bunting; Laurie S Tsuruda; Charles A O'Neill
Journal:  Mol Genet Metab       Date:  2011-06-30       Impact factor: 4.797

Review 6.  Use of model organisms for the study of neuronal ceroid lipofuscinosis.

Authors:  Michael Bond; Sophia-Martha Kleine Holthaus; Imke Tammen; Guy Tear; Claire Russell
Journal:  Biochim Biophys Acta       Date:  2013-01-18

7.  Quantitative assessment of the canine pupillary light reflex.

Authors:  Rebecca E H Whiting; Gang Yao; Kristina Narfström; Jacqueline W Pearce; Joan R Coates; John R Dodam; Leilani J Castaner; Martin L Katz
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

8.  Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.

Authors:  Kristina Narfström; Martin L Katz; Ragnheidur Bragadottir; Mathias Seeliger; Ana Boulanger; T Michael Redmond; Lynette Caro; Chooi-May Lai; P Elizabeth Rakoczy
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-04       Impact factor: 4.799

9.  The neuronal ceroid-lipofuscinoses: a historical introduction.

Authors:  Matti Haltia; Hans H Goebel
Journal:  Biochim Biophys Acta       Date:  2012-08-29

10.  Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients.

Authors:  Paolo Melillo; Leandro Pecchia; Francesco Testa; Settimio Rossi; Jean Bennett; Francesca Simonelli
Journal:  Biomed Eng Online       Date:  2012-07-19       Impact factor: 2.819

View more
  9 in total

1.  Intravitreal enzyme replacement preserves retinal structure and function in canine CLN2 neuronal ceroid lipofuscinosis.

Authors:  Rebecca E H Whiting; Jacqueline W Pearce; Daniella P Vansteenkiste; Katherine Bibi; Stefanie Lim; Grace Robinson Kick; Leilani J Castaner; John Sinclair; Sundeep Chandra; Annalisa Nguyen; Charles A O'Neill; Martin L Katz
Journal:  Exp Eye Res       Date:  2020-07-01       Impact factor: 3.467

2.  Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis.

Authors:  Rebecca E H Whiting; Jacqueline W Pearce; Leilani J Castaner; Cheryl A Jensen; Rebecca J Katz; Douglas H Gilliam; Martin L Katz
Journal:  Exp Eye Res       Date:  2015-02-16       Impact factor: 3.467

3.  A Novel Porcine Model of CLN2 Batten Disease that Recapitulates Patient Phenotypes.

Authors:  Vicki J Swier; Katherine A White; Tyler B Johnson; Jessica C Sieren; Hans J Johnson; Kevin Knoernschild; Xiaojun Wang; Frank A Rohret; Christopher S Rogers; David A Pearce; Jon J Brudvig; Jill M Weimer
Journal:  Neurotherapeutics       Date:  2022-09-13       Impact factor: 6.088

4.  Intravitreal enzyme replacement inhibits progression of retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis.

Authors:  Rebecca E H Whiting; Grace Robinson Kick; Juri Ota-Kuroki; Stefanie Lim; Leilani J Castaner; Cheryl A Jensen; Joseph Kowal; Annalisa Nguyen; Carley Corado; Charles A O'Neill; Martin L Katz
Journal:  Exp Eye Res       Date:  2020-07-04       Impact factor: 3.770

5.  Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression.

Authors:  M L Katz; G C Johnson; S B Leach; B G Williamson; J R Coates; R E H Whiting; D P Vansteenkiste; M S Whitney
Journal:  Gene Ther       Date:  2017-02-02       Impact factor: 5.250

6.  Assessment of Rod, Cone, and Intrinsically Photosensitive Retinal Ganglion Cell Contributions to the Canine Chromatic Pupillary Response.

Authors:  Connie Y Yeh; Kristin L Koehl; Christine D Harman; Simone Iwabe; José M Guzman; Simon M Petersen-Jones; Randy H Kardon; András M Komáromy
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

7.  CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease).

Authors:  S L Eaton; C Proudfoot; S G Lillico; P Skehel; R A Kline; K Hamer; N M Rzechorzek; E Clutton; R Gregson; T King; C A O'Neill; J D Cooper; G Thompson; C B Whitelaw; T M Wishart
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

8.  Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease).

Authors:  Martin L Katz; Joan R Coates; Christine M Sibigtroth; Jacob D Taylor; Melissa Carpentier; Whitney M Young; Fred A Wininger; Derek Kennedy; Brian R Vuillemenot; Charles A O'Neill
Journal:  J Neurosci Res       Date:  2014-06-17       Impact factor: 4.164

9.  Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.

Authors:  Rebecca E H Whiting; Cheryl A Jensen; Jacqueline W Pearce; Lauren E Gillespie; Daniel E Bristow; Martin L Katz
Journal:  Exp Eye Res       Date:  2016-04-01       Impact factor: 3.467

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.